Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
435 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04781712 | Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer(MMHTR) | completed | N/A | 44 | Samsung Medical CenterOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT04787029 | Effect of Prophylactic Medical Compression Therapy on the Reduction of Breast Cancer-related Lymphedema in Patients With Adjuvant Docetaxel Chemotherapy: a Randomized Controlled Study | unknown | N/A | 150 | Samsung Medical CenterOTHER | 1 | Oct 26, 2022 |
| clinicaltrials |
| NCT04907591 | Postoperative Prognosis Management Service Based mHealth for Gastric Cancer Patients | unknown | N/A | 324 | Samsung Medical CenterOTHER | 1 | Oct 26, 2022 | clinicaltrials |
| NCT05566249 | A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry | recruiting | — | 1,000 | Samsung Medical CenterOTHER | 1 | Oct 6, 2022 | clinicaltrials |
| NCT04277845 | Randomized Phase II Study in Elderly Patients With Newly Diagnosed Multiple Myeloma(KMM1910) | unknown | Phase 2 | 49 | Samsung Medical CenterOTHER | 1 | Sep 9, 2022 | clinicaltrials |
| NCT05509374 | Phase II Study of Carfilzomib, Pomalidomide, and Dexamethasone for Myeloma Patients Who Had Relapsed or Progressed After Carfilzomib, Lenalidomide, and Dexamethasone(KMM2002) | unknown | Phase 2 | 33 | Samsung Medical CenterOTHER | 1 | Aug 22, 2022 | clinicaltrials |
| NCT05497102 | Carfilzomib, Lenalidomide, and Dexamethasone Re-induction Followed by the 2nd ASCT in Multiple Myeloma Patients Relapsed After the 1st ASCT(KMM1911) | unknown | Phase 2 | 58 | Samsung Medical CenterOTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03163992 | Pembrolizumab in Advanced Hepatocellular Carcinoma as Second-line Treatment After Failure of Sorafenib | completed | Phase 2 | 60 | Samsung Medical CenterOTHER | 1 | Aug 8, 2022 | clinicaltrials |
| NCT01831609 | Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer | unknown | — | 1,000 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02140463 | Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial) | completed | — | 229 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02299648 | The Screening Protocol for The VIKTORY Trial | completed | N/A | 651 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02447419 | Study to Evaluate the Safety and Efficacy of Gefitinib, in Subjects With EFGR Amplification Refractory Solid Tumors | completed | Phase 2 | 16 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02450123 | Single-arm Study to Evaluate the Safety and Efficacy of Sunitinib, in Subjects With RET Fusion Positive or FGFR2 Amplification, Refractory Solid Tumors | completed | N/A | 1 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02450136 | Single-arm Study to Evaluate the Safety and Efficacy of Pazopanib, in Subjects With FGFR2 Amplification, FGFR2 Mutation Refractory Solid Tumors | completed | N/A | 2 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02461849 | Patients With Refractory, Metastatic Cancer Harboring KIT Mutation or Amplification to Investigate the Clinical Efficacy and Safety of Imatinib Therapy | unknown | Phase 2 | 14 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02588781 | Pemetrexed Alone as Salvage Treatment in Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy: A Phase II Single Arm Prospective Study | unknown | Phase 2 | 23 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02593578 | Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic. | unknown | — | 2,000 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02630199 | Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer | completed | Phase 1 | 65 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02646228 | Establishment of Patient Derived Cancer Cell Models to Interrogate Novel Molecular Targets in Metastatic Cancer | unknown | — | 500 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02688881 | Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors | completed | Phase 4 | 6 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02691767 | Study to Evaluate the Safety and Efficacy of Pazopanib, in Subject With Refractory Solid Tumors | completed | N/A | 2 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT02691793 | Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors | completed | Phase 4 | 1 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT03086538 | Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy | completed | Phase 2 | 29 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT03110510 | FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study | withdrawn | Phase 2 | 0 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT03170180 | Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer | completed | Phase 2 | 66 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT04258072 | Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma. | unknown | Phase 1 | 24 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT04401709 | Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer | unknown | Phase 3 | 490 | Samsung Medical CenterOTHER | 1 | Jun 15, 2022 | clinicaltrials |
| NCT04546828 | A Single-arm Study of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Resectable Oncologically High-Risk IHCC in Korea | withdrawn | Phase 2 | 0 | Samsung Medical CenterOTHER | 0 | Jun 15, 2022 | clinicaltrials |
| NCT05377788 | Lazertinib Real-world Observational Study of in Pre-treated EGFR T790M Mutant With Advanced Non-small Cell Lung Cancer | unknown | — | 900 | Samsung Medical CenterOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT01585545 | Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers | unknown | — | 500 | Samsung Medical CenterOTHER | 1 | May 5, 2022 | clinicaltrials |
| NCT02535650 | Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma | unknown | Phase 2 | 19 | Samsung Medical CenterOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT03061630 | A Prospective Study of Neoadjuvant Chemotherapy With Gemcitabine/Platinum in Muscle-Invasive or Locally-Advanced Urothelial Carcinoma of Bladder | unknown | Phase 2 | 49 | Samsung Medical CenterOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT03061643 | An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma | unknown | Phase 2 | 42 | Samsung Medical CenterOTHER | 1 | Mar 8, 2022 | clinicaltrials |
| NCT04253509 | Liquid Biopsy Using Methylation Sequencing for Lung Cancer | completed | — | 280 | Samsung Medical CenterOTHER | 1 | Feb 8, 2022 | clinicaltrials |
| NCT03766516 | Registry of BrentuximabVedotinin Patients With R/R Anaplastic Large Cell Lymphoma or Classical HL(BRAVO) | completed | — | 90 | Samsung Medical CenterOTHER | 1 | Feb 7, 2022 | clinicaltrials |
| NCT05193357 | Home-based Intermittent Pneumatic Compression Therapy for Gynecologic Cancer | completed | N/A | 30 | Samsung Medical CenterOTHER | 1 | Jan 14, 2022 | clinicaltrials |
| NCT03614364 | Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma | unknown | Phase 2 | 41 | Samsung Medical CenterOTHER | 1 | Jan 4, 2022 | clinicaltrials |
| NCT04316156 | Real-time Interactive Digital Healthcare System in Patients With Breast Cancer; Randomized Controlled Trial | completed | N/A | 100 | Samsung Medical CenterOTHER | 1 | Dec 16, 2021 | clinicaltrials |
| NCT05097404 | Clinical Utility of VI-RADS in Diagnosis of MIBC | unknown | — | 73 | Samsung Medical CenterOTHER | 1 | Oct 28, 2021 | clinicaltrials |
| NCT03975179 | Omitting vs. Doing Intraoperative Frozen Section Biopsy for Margin Status in Breast Conserving Surgery(OFF-MAP) | unknown | N/A | 1,292 | Samsung Medical CenterOTHER | 1 | Oct 21, 2021 | clinicaltrials |
| NCT03439501 | Avelumab in Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma[AVENT STUDY] | unknown | Phase 2 | 21 | Samsung Medical CenterOTHER | 1 | Sep 24, 2021 | clinicaltrials |
| NCT05024331 | A Prediction Model of Hematological Recovery After High-dose Chemotherapy in Pediatric Solid Tumor | completed | — | 10 | Samsung Medical CenterOTHER | 1 | Sep 13, 2021 | clinicaltrials |
| NCT04922073 | Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC | unknown | — | 150 | Samsung Medical CenterOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT05008237 | Weekly Docetaxel Plus Cisplatin as First-line Chemotherapy in Metastatic Salivary Gland Cancer Patients : a Multicenter Phase II Study | unknown | Phase 2 | 42 | Samsung Medical CenterOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT03257124 | Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMS | unknown | Phase 2 | 80 | Samsung Medical CenterOTHER | 1 | Aug 16, 2021 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials